However, high adiponectin concentrations have been associated with adverse cardiovascular outcomes in adult patients with ischemic heart disease, chronic heart failure and CKD, which has been called the “adiponectin paradox” (11–13). Here, ADIPOQ is linked to chronic kidney disease.